MiR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 411, Issue 3, 2011, Pages 586-592

  Wang, Chun Mei ^a   Wang, Yan ^a   Fan, Chun Guang ^a   Xu, Fei Fei ^a   Sun, Wen Sheng ^a   Liu, Yu Gang ^a   Jia, Ji Hui ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatitis B virus (HBV); Hepatocellular carcinoma (HCC); MicroRNA; MiR 29c; TNFAIP3

Indexed keywords

MICRORNA; MICRORNA 29C; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; VIRUS DNA;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; DNA REPLICATION; DOWN REGULATION; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MICRORNAS; NUCLEAR PROTEINS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 79961126724     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.191     Document Type: Article

References (23)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Carleton M., Cleary M.A., Linsley P.S. MicroRNAs and cell cycle regulation. Cell Cycle 2007, 6:2127-2132.
3. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
4. Skaftnesmo K.O., Prestegarden L., Micklem D.R., Lorens J.B. MicroRNAs in tumorigenesis. Curr. Pharm. Biotechnol. 2007, 8:320-325.
5. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
6. But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1652-1656.
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11:97-107.
8. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C.D., Chan K.K., Marcucci G., Calin G.A., Huebner K., Croce C.M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104:15805-15810.
9. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., Zanetti K.A., Ye Q.H., Qin L.X., Croce C.M., Tang Z.Y., Wang X.W. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47:897-907.
10. Liu Y., Zhao J.J., Wang C.M., Li M.Y., Han P., Wang L., Cheng Y.Q., Zou L.F., Ma X., Xu D.P. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin. Med. J. (Engl.) 2009, 122:10-14.
11. Roderburg C., Urban G.M., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., Tacke F., Trautwein C., Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:4-6.
12. Gao P., Wong C.C., Tung E.K., Lee J.M., Wong C.M., Ng I.O. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J. Hepatol. 2011, 54:1177-1184.
13. Kole A.J., Swahari V., Hammond S.M., Deshmukh M. MiR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 2011, 25:125-130.
14. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., Lin C.D., Liao Y.L., Wang J.L., Chau Y.P., Hsu M.T., Hsiao M., Huang H.D., Tsou A.P. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009, 49:1571-1582.
15. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
16. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., Rana T.M. Celluar microRNA and P-bodies modulate host-HIV-1 interactions. Mol. Cell 2009, 34:696-709.
17. Gao Y.F., Yu L., Wei W., Li J.B., Luo Q.L., Shen J.L. HBV replication and gene expression can be strongly inhibited with virus specific siRNA treatment. World J. Gastroenterol. 2008, 14:4684-4689.
18. Sun F., Fu H.J., Liu Q., Tie Y., Zhu J., Xing R.Y., Sun Z.X., Zheng X.F. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008, 582:1564-1568.
19. Nguyen T., Kuo C., Nicholl M.B., Sim M.S., Turner R.R., Morton D.L., Hoon D.S. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 2011, 6:388-394.
20. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., Ferran C. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J. Biol. Chem. 1996, 271:18068-18073.
21. Wertz I.E., Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430:694-699.
22. Codd J.D., Salisbury J.R., Packham G., Nicholson L.J. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J. Pathol. 1999, 187:549-555.
23. Lin R., Yang L., Nakhaei P., Sun Q., Sharif-Askari E., Julkunen I., Hiscott J. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 2006, 281:2095-2103.